What a stupid comment on ROE. ROE cannot be calculated on zero revenue.
MSB has only just entered the revenue game, its to early to be talking ROE and targets. Also this medical science company and making early and progressive sales updates and patients numbers outside the ususal 4c report periods is immoral and insensitive. Especially when each full treatment cycle costs USD$1.5m to save a childs life. Is doesn't look good trying to spark up the share price with sales updates outside the usual windows in this line of business.
Just be patient the 4c is due end July and that will give an indication of patiets numbers and sales
MSB Price at posting:
$1.74 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)